Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors

J Neurosci. 2000 May 1;20(9):3504-11. doi: 10.1523/JNEUROSCI.20-09-03504.2000.

Abstract

By increasing dopamine (DA) release and activating feedback mechanisms, amphetamine and related psychostimulants are known to inhibit DA cell firing. Here, we report that D-amphetamine also has an excitatory effect on DA cells, which under control conditions, is masked by the inhibitory effect of D-amphetamine and is revealed when D2-like receptors are blocked. Thus, using in vivo single-unit recording in rats, we found that the selective D2 antagonist raclopride not only blocked the inhibition induced by D-amphetamine but also enabled D-amphetamine to excite DA cells. The excitation, expressed as an increase in both firing rate and bursting, persisted when both D1- and D2-like receptors were blocked by SCH23390 and eticlopride, suggesting that it is not mediated by DA receptors. The norepinephrine uptake blocker nisoxetine mimicked the effect of D-amphetamine, especially the increase in bursting, whereas the 5-HT uptake blocker fluoxetine produced no significant effect. Adrenergic alpha1 antagonists prazosin and WB4101 and the nonselective alpha antagonist phenoxybenzamine completely blocked increase in bursting induced by D-amphetamine and partially blocked the increase in firing rate. The alpha2 antagonist idazoxan and the beta antagonist propranolole, however, failed to prevent D-amphetamine from producing the excitation. Thus, revising the traditional concept, this study suggests that D-amphetamine has two effects on DA cells, a DA-mediated inhibition and a non-DA-mediated excitation. The latter is mediated in part through adrenergic alpha1 receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Dextroamphetamine / pharmacology*
  • Dopamine Agents / pharmacology*
  • Dopamine Antagonists / pharmacology
  • Male
  • Neurons / drug effects*
  • Neurons / physiology
  • Raclopride / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha / drug effects*
  • Receptors, Adrenergic, alpha / physiology
  • Receptors, Dopamine / drug effects*
  • Receptors, Dopamine / physiology
  • Substantia Nigra / drug effects
  • Substantia Nigra / physiology
  • Ventral Tegmental Area / drug effects
  • Ventral Tegmental Area / physiology

Substances

  • Adrenergic alpha-Antagonists
  • Dopamine Agents
  • Dopamine Antagonists
  • Receptors, Adrenergic, alpha
  • Receptors, Dopamine
  • Raclopride
  • Dextroamphetamine